1. Home
  2. WVE vs SPFI Comparison

WVE vs SPFI Comparison

Compare WVE & SPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$3.88

Market Cap

744.8M

Sector

Health Care

ML Signal

N/A

Logo South Plains Financial Inc.

SPFI

South Plains Financial Inc.

N/A

Current Price

$42.28

Market Cap

812.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
SPFI
Founded
2012
1941
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
744.8M
812.0M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
WVE
SPFI
Price
$3.88
$42.28
Analyst Decision
Strong Buy
Buy
Analyst Count
18
4
Target Price
$18.53
★ $50.75
AVG Volume (30 Days)
★ 2.8M
89.4K
Earning Date
11-09-2026
10-22-2026
Dividend Yield
N/A
★ 1.73%
EPS Growth
N/A
★ 17.81
EPS
N/A
★ 1.82
Revenue
★ $3,704,000.00
N/A
Revenue This Year
$20.53
$17.14
Revenue Next Year
N/A
$9.15
P/E Ratio
★ N/A
$23.07
Revenue Growth
★ 149.43
N/A
52 Week Low
$3.56
$35.34
52 Week High
$21.73
$46.94

Technical Indicators

Market Signals
Indicator
WVE
SPFI
Relative Strength Index (RSI) 36.57 N/A
Support Level N/A N/A
Resistance Level $6.33 N/A
Average True Range (ATR) 0.21 0.00
MACD -0.02 0.00
Stochastic Oscillator 38.99 0.00

Price Performance

Historical Comparison
WVE
SPFI

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About SPFI South Plains Financial Inc.

South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking. The majority of the company's revenues is derived from interest income and other sources, including loans, securities and derivatives.

Share on Social Networks: